Form 8-K - Current report:
SEC Accession No. 0001493152-22-029389
Filing Date
2022-10-24
Accepted
2022-10-24 08:58:20
Documents
31
Period of Report
2022-10-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40671
2 ex99-1.htm EX-99.1 14818
3 ex99-2.htm EX-99.2 16376
4 ex99-1_001.jpg GRAPHIC 401408
5 ex99-1_002.jpg GRAPHIC 813125
6 ex99-1_003.jpg GRAPHIC 299429
7 ex99-1_004.jpg GRAPHIC 255748
8 ex99-1_005.jpg GRAPHIC 348499
9 ex99-1_006.jpg GRAPHIC 342827
10 ex99-1_007.jpg GRAPHIC 299956
11 ex99-1_008.jpg GRAPHIC 229752
12 ex99-1_009.jpg GRAPHIC 300959
13 ex99-1_010.jpg GRAPHIC 310220
14 ex99-1_011.jpg GRAPHIC 357791
15 ex99-1_012.jpg GRAPHIC 187030
16 ex99-1_013.jpg GRAPHIC 257019
17 ex99-1_014.jpg GRAPHIC 358977
18 ex99-1_015.jpg GRAPHIC 397515
19 ex99-2_001.jpg GRAPHIC 3022
20 ex99-2_002.jpg GRAPHIC 3022
  Complete submission text file 0001493152-22-029389.txt   7366525

Data Files

Seq Description Document Type Size
21 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT envb-20221023.xsd EX-101.SCH 3224
22 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT envb-20221023_lab.xml EX-101.LAB 34240
23 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT envb-20221023_pre.xml EX-101.PRE 22357
25 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3743
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 221324904
SIC: 2834 Pharmaceutical Preparations